Lobbying Information
Subject Matters
- Employment and Training
- Health
- Justice and Law Enforcement
- Labour
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Funding from the federal government for research related to arthritis and to support patient oriented research
Legislative Proposal, Bill or Resolution
- Discussions with government officials with respect to the legalization and regulation of marijuana as it relates to medical cannabis policy
Legislative Proposal, Bill or Resolution, Regulation
- Employment Insurance Act, specifically with respect to episodic disabilities and/or caregivers
- Food and Drugs Act and Regulations, specifically with respect to the special access programme for patients living with arthritis
Policies or Program
- Advocacy for development of a coordinated national strategy for musculoskeletal conditions that will align strategic directions, exchange best practices and integration of prevention, detection and management systems across Canada
- Communication with federal government officials with respect to promoting research and federal-provincial coordination in best practices for arthritis patient care
- Engagement with the Advisory Committee on the Implementation of National Pharmacare and its Secretariat on issues related to medicines for chronic diseases, such as arthritis.
- Health Canada's office of pharmaceutical management strategies, specifically with respect to Health Canada's role in supporting and directing federal, national and inter-jurisdictional pharmaceutical policy
- Promoting workplace productivity and wellness initiatives for musculoskeletal health
Policies or Program, Regulation
- Excise Tax Act, specifically with respect to the application of sales tax on medical cannabis
Regulation
- Canada Pension Plan, specifically the term "severe and prolonged" in s. 42 to broaden its application to more Canadians.
- Patented Medicine Prices Review Board, specifically with respect to the regulation of pricing of patented drug products
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Employment and Social Development Canada (ESDC)
-
Finance Canada (FIN)
-
Health Canada (HC)
-
House of Commons
-
Justice Canada (JC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Safety Canada (PS)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
393 University Avenue, Suite 1700, Toronto, ON M5G 1E6
Toronto, ON M5G 1E6
Canada
Telephone number:
416-979-2563
Web address:
https://arthritis.ca/
Client representative
Janet Yale, President and CEO
Parent Company Information
The Arthritis Society / La Société de l'arthrite is not a subsidiary of any other parent companies.
Coalition Members Information
The Arthritis Society / La Société de l'arthrite is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of The Arthritis Society / La Société de l'arthrite are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
The Arthritis Society / La Société de l'arthrite does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Philip Delistoyanov
|
No public offices held
Business address:
130 Albert Street, Suite 408
Ottawa, ON K1P 5G4
Canada
Telephone number:
613-864-2934
Consultant Firm and Address
Firm:
3Sixty Public Affairs
Address:
130 Albert Street, Suite 408
Ottawa, ON K1P 5G4
Canada
Telephone number:
613-864-2934
